CRIS

Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26 TTM Total revenue 2.38 M2.75 M3.18 M1.14 M0 7.06 M Gross profit 2.38 M2.75 M3.18 M1.14 M0 7.06 M Operating expenses 4.06 M3.58 M3.7 M2.92 M5.08 M 15.28 M Selling/general/admin expenses 3.98 M3.53 M3.65 M2.88 M5.07 M 15.13 M Research & development 8.54 M7.46 M6.43 M5.83 M6.45 M 26.16 M Operating income -10.16 M-8.25 M-6.92 M19.62 M-11.52 M -7.08 M Non-Operating Income, Total -459 K-342 K-805 K-263 K-12.68 M -14.09 M Interest expense, net of interest capitalized ————— — Non-Operating Income, excl. Interest Expenses -459 K-342 K-805 K-263 K-12.68 M -14.09 M Unusual income/expense ————— — Pretax income -10.62 M-8.59 M-7.73 M19.36 M-24.2 M -21.16 M Equity in earnings ————— — Taxes ———2.53 M— — Non-controlling/minority interest ————— — After tax other income/expense ————— — Net income before discontinued operations -10.62 M-8.59 M-7.73 M19.36 M-24.2 M -21.16 M Discontinued operations ————— — Net income -10.62 M-8.59 M-7.73 M19.36 M-24.2 M -21.16 M Dilution adjustment ————— — Preferred dividends ————— — Diluted net income available to common stockholders -10.62 M-8.59 M-7.73 M19.36 M-24.2 M -21.16 M Basic earnings per share (Basic EPS) -25-13.6-9.836.8-25 -11.6 Diluted earnings per share (Diluted EPS) -25-13.6-9.836.8-25 -11.6 Average basic shares outstanding 424.69 K631.38 K784.01 K658.2 K968.17 K — Diluted shares outstanding 424.69 K631.38 K784.01 K658.2 K968.17 K — EBITDA -10.16 M-8.25 M-6.92 M-7.57 M— — EBIT -10.16 M-8.25 M-6.92 M-7.57 M-11.52 M -34.26 M Cost of revenue ————— — Other cost of goods sold ————— — Depreciation & amortization (cash flow) 0000— —